% | $
Quotes you view appear here for quick access.

Allergan plc Message Board

angelofoca 8 posts  |  Last Activity: Nov 18, 2015 9:13 PM Member since: Dec 15, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    A good reason

    by angelofoca Nov 17, 2015 11:18 AM
    angelofoca angelofoca Nov 18, 2015 9:13 PM Flag

    But can you give me a good reason as to why someone would - for years, and years - hang around a MB spewing the same bull over and over and over and over???

    I can only think of one good reason, and that is that he got FIRED by the Nigerian CEO.

    Oh my god... gregori got canned by a Nigerian goat herder because he got caught with one of the goat herder's GOATS - he swore up and down that his intentions towards the juvenile goat were honorable - but the nigerian goat herder couldn't get over the fact that you had chosen a BILLY GOAT.. and so he CANNED YOU ! ! !

    Cheer up gregori - heart breaks like that only hurt for about two or three years - so you're approaching the end of the morning period.

    ps - in 3 or 4 years, when IPCI hits 50 bucks a share, I'm going to get me one of those yellow Lamborghini - can't wait.

  • Reply to

    A good reason

    by angelofoca Nov 17, 2015 11:18 AM
    angelofoca angelofoca Nov 17, 2015 11:57 AM Flag

    Well I can't do it - I can't spread mis-information as the AHs on this board do - so in fairness you would have to bring the current share prices to parity for a proper comparison - so if you did a 1 for 6 reverse split on ELTP, the price would be 1.80 and shares outstanding would be ~ 115 million - so they would have to earn $115 Million - still ROFLMFAO

  • angelofoca by angelofoca Nov 17, 2015 11:18 AM Flag

    dig a little deeper says - If you have a good reason not to buy ELTP I am all ears.*
    How about this - For IPCI to earn $1.00 per share... it has to earn $24 million - easily do-able and SOON.
    For ELTP to earn $1.00 per share... READY FOR THIS??? it has to earn $685 Million - YEA - LOL - $685 MILLION

  • angelofoca by angelofoca Sep 19, 2015 2:03 PM Flag

    Looking at the yahoo stock chart - what I see is that 178K traded at $2.61 not $2.92 - the $2.92 was a trade at the very end of day for 1K share and it may have been someone who in error keyed in $2.92 rather than $2.62

  • Reply to

    Seroquel XR potential

    by angelofoca Sep 18, 2015 2:13 PM
    angelofoca angelofoca Sep 19, 2015 1:30 PM Flag

    Don't agree with that at all - I don't think percentage has anything at all to do with market potential - It all has to do with how far along the path to approval the drug is - preclinical gets you 5% to 8 % - successful phase 1 about 10% to 15% - phase 2 , about 15 to 25 % phase 3 = 25 to 35% - FDA approved = 35 to 50% and usually the lower the percentage the bigger the milestone payments. - IPCI would be handing over a ready for market drug with 180 days exclusivity... if they don't get 50% they should get a very hefty up front payment.

  • Reply to

    SEC Filling: SCHEDULE 14A

    by orfelioulises Sep 18, 2015 9:53 PM
    angelofoca angelofoca Sep 19, 2015 1:01 PM Flag

    If good news does emerge... then whoever bought those shares is in deep do-do - because he/she acted on inside information... and it would be relatively simple to find out who it is.

  • angelofoca angelofoca Sep 18, 2015 4:35 PM Flag

    If I recall right, they did receive $5 million up front, and Novartis bought a couple of million shares of stock

  • angelofoca by angelofoca Sep 18, 2015 2:13 PM Flag

    When Will the Generic Be Available?: Some or all forms of Seroquel XR may become available as generic quetiapine xr after November 2016, depending on FDA approval and patent expiration.

    I believe IPCI was first to file and has 180 day exclusivity on all 5 strenghts, and I believe this is the drug that they have partnered with TEVA.

    p.s. Seroquel XR is a $1.2 BILLION drug - 6 months exclusivity = $600 Million x 60% (40% discount over brand name) = $360 million x 25% market capture during 6 month exclusivity = $90 million x 50% (50/50 split with Teva - most likely) = $45 million divided by 25 million shares = $1.80 earnings per share for 6 months x 20 p/e (reasonable for growing concern) = $36.00 +/- 20% = ~ $28.80 to $43.20 fair value per share... just on Seroquel XR.

    Sentiment: Strong Buy

319.76-0.50(-0.16%)Nov 27 1:02 PMEST